肾小球硬化能逆转吗？ - Suppr

Suppr

超能文献

Can glomerulosclerosis be reversed?

作者信息

Fogo Agnes B

机构信息

MCN C3310, Department of Pathology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

出版信息

Nat Clin Pract Nephrol. 2006 Jun;2(6):290-1. doi: 10.1038/ncpneph0200.

DOI:10.1038/ncpneph0200

PMID:16932443

Abstract

摘要

相似文献

Can glomerulosclerosis be reversed?

Nat Clin Pract Nephrol. 2006 Jun;2(6):290-1. doi: 10.1038/ncpneph0200.

Glomerular scarring: can we delay or even reverse glomerulosclerosis by RAAS inhibition?

Nephrol Dial Transplant. 2010 Jul;25(7):2101-3. doi: 10.1093/ndt/gfq182. Epub 2010 Apr 12.

ACE inhibition and glomerular repair: restructuring or regeneration?

Kidney Int. 2006 Apr;69(7):1105-7. doi: 10.1038/sj.ki.5000237.

[Study on renoprotective effect of Xuebijing and Rosiglitazone in rats with focal segmental glomerular fibrosis].

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 May;20(5):299-300.

A clinical approach in regression of glomerulosclerosis.

Rom J Intern Med. 2007;45(2):215-8.

Early, but not late therapy with a vasopressin V1a-antagonist ameliorates the development of renal damage after 5/6 nephrectomy.

J Renin Angiotensin Aldosterone Syst. 2006 Dec;7(4):217-24. doi: 10.3317/jraas.2006.041.

Review on diagnosis and treatment of focal segmental glomerulosclerosis.

Neth J Med. 2008 Jan;66(1):3-12.

Spontaneous glomerulosclerosis: insights from the fawn-hooded rat.

Kidney Int Suppl. 1994 Feb;45:S2-5.

The pros and cons of plasmapheresis therapy carried out on time.

Nefrologia. 2013;33(5):741-2. doi: 10.3265/Nefrologia.pre2013.Jun.12061.

Focal segmental glomerulosclerosis: a case study with review of pathophysiology.

Nephrol Nurs J. 2007 Mar-Apr;34(2):176-82.

引用本文的文献

Animal models mimicking aminoglycoside-induced renal damage.

J Nephropharmacol. 2016 Jan 6;5(1):1-3. eCollection 2016.

The targeted podocyte.

J Clin Invest. 2011 Jun;121(6):2142-5. doi: 10.1172/JCI57935. Epub 2011 May 23.

Increased capillary branching contributes to angiotensin type 1 receptor blocker (ARB)-induced regression of sclerosis.

Am J Pathol. 2011 Apr;178(4):1891-8. doi: 10.1016/j.ajpath.2010.12.029. Epub 2011 Mar 3.

PAI-1 and kidney fibrosis.

Front Biosci (Landmark Ed). 2009 Jan 1;14(6):2028-41. doi: 10.2741/3361.

Modulation of glomerulosclerosis.

Semin Immunopathol. 2007 Nov;29(4):385-95. doi: 10.1007/s00281-007-0087-y. Epub 2007 Sep 8.

Renin-angiotensin axis blockade reduces proteinuria in presymptomatic patients with familial FSGS.

Pediatr Nephrol. 2007 Oct;22(10):1779-84. doi: 10.1007/s00467-007-0505-3. Epub 2007 May 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Can glomerulosclerosis be reversed?

Nat Clin Pract Nephrol. 2006 Jun;2(6):290-1. doi: 10.1038/ncpneph0200.

Glomerular scarring: can we delay or even reverse glomerulosclerosis by RAAS inhibition?

Nephrol Dial Transplant. 2010 Jul;25(7):2101-3. doi: 10.1093/ndt/gfq182. Epub 2010 Apr 12.

ACE inhibition and glomerular repair: restructuring or regeneration?

Kidney Int. 2006 Apr;69(7):1105-7. doi: 10.1038/sj.ki.5000237.

[Study on renoprotective effect of Xuebijing and Rosiglitazone in rats with focal segmental glomerular fibrosis].

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 May;20(5):299-300.

A clinical approach in regression of glomerulosclerosis.

Rom J Intern Med. 2007;45(2):215-8.

Early, but not late therapy with a vasopressin V1a-antagonist ameliorates the development of renal damage after 5/6 nephrectomy.

J Renin Angiotensin Aldosterone Syst. 2006 Dec;7(4):217-24. doi: 10.3317/jraas.2006.041.

Review on diagnosis and treatment of focal segmental glomerulosclerosis.

Neth J Med. 2008 Jan;66(1):3-12.

Spontaneous glomerulosclerosis: insights from the fawn-hooded rat.

Kidney Int Suppl. 1994 Feb;45:S2-5.

The pros and cons of plasmapheresis therapy carried out on time.

Nefrologia. 2013;33(5):741-2. doi: 10.3265/Nefrologia.pre2013.Jun.12061.

Focal segmental glomerulosclerosis: a case study with review of pathophysiology.

Nephrol Nurs J. 2007 Mar-Apr;34(2):176-82.

引用本文的文献

Animal models mimicking aminoglycoside-induced renal damage.

J Nephropharmacol. 2016 Jan 6;5(1):1-3. eCollection 2016.

The targeted podocyte.

J Clin Invest. 2011 Jun;121(6):2142-5. doi: 10.1172/JCI57935. Epub 2011 May 23.

Increased capillary branching contributes to angiotensin type 1 receptor blocker (ARB)-induced regression of sclerosis.

Am J Pathol. 2011 Apr;178(4):1891-8. doi: 10.1016/j.ajpath.2010.12.029. Epub 2011 Mar 3.

PAI-1 and kidney fibrosis.

Front Biosci (Landmark Ed). 2009 Jan 1;14(6):2028-41. doi: 10.2741/3361.

Modulation of glomerulosclerosis.

Semin Immunopathol. 2007 Nov;29(4):385-95. doi: 10.1007/s00281-007-0087-y. Epub 2007 Sep 8.

Renin-angiotensin axis blockade reduces proteinuria in presymptomatic patients with familial FSGS.

Pediatr Nephrol. 2007 Oct;22(10):1779-84. doi: 10.1007/s00467-007-0505-3. Epub 2007 May 25.